文献速递围术期管理与 ERAS急腹症与外科感染

移植受者状态与大型手术后临床及经济结局的关联

Association of transplant recipient status with clinical and financial outcomes among patients undergoing major surgery.
PubMed 文献 · Surgery · 2024-11-28

该研究基于2016至2020年全国再入院数据库,纳入1,818,973例接受大型非移植手术的患者,其中0.45%有实体器官移植史。经熵平衡后多变量回归显示,移植史与术后并发症、30天再入院及院内死亡风险升高相关,且住院和出院后30天费用更高。

要点

  • 移植受者接受大型非移植手术时并发症风险升高(OR 1.30)。
  • 移植史与30天再入院(OR 1.42)和院内死亡(OR 1.20)风险增加相关。
  • 移植受者住院费用和出院后30天费用分别高出14.4%和16.2%。

核心结论

  • 既往实体器官移植状态与后续大型手术的不良临床和经济结局相关。
  • 移植史可能是后续大型手术风险分层的重要考虑因素。

研究设计与样本

  • 回顾性队列研究,使用2016至2020年全国再入院数据库。
  • 纳入接受全肺切除、冠状动脉旁路移植、腹主动脉瘤修复、Whipple手术或结肠切除术的患者共1,818,973例。
  • 采用熵平衡后多变量回归模型评估移植状态与结局的关系。

主要发现

  • 移植受者占0.45%(n=8,212),其中肾/胰腺移植59.6%、肝移植21.6%、心/肺移植13.2%、多器官移植5.6%。
  • 未匹配队列中移植受者男性比例64.1% vs 57.7%,Medicare保险比例71.7% vs 59.3%(均P < .001)。
  • 移植史与术后并发症风险升高相关(OR 1.30,95%CI 1.22-1.38)。
  • 移植史与30天再入院风险升高相关(OR 1.42,95%CI 1.31-1.54)。
  • 移植史与院内死亡风险升高相关(OR 1.20,95%CI 1.03-1.40)(均P < .05)。

关键数值与推荐

  • 移植史与住院费用差异增加14.4%(95%CI 14.1%-14.6%)相关(P < .001)。
  • 移植史与出院后30天费用差异增加16.2%(95%CI 15.3%-17.0%)相关(P < .001)。

临床怎么用

  • 对既往移植受者行大型手术前应强化风险评估与围术期管理。
  • 移植史可作为术后并发症、再入院和死亡风险的预警因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transplant recipients undergoing surgery may represent a vulnerable population because of transplant-related comorbidities as well as reliance on immunosuppressive medications. We sought to characterize the association of prior transplant status on postoperative outcomes among patients undergoing major non-transplant-related surgical procedures. METHODS: Data on patients who underwent a major surgical procedure (pneumonectomy, coronary artery bypass graft, abdominal aortic aneurysm repair, Whipple, colectomy) between 2016 and 2020 were obtained from the Nationwide Readmission Database. After balancing the 2 cohorts using entropy balancing, multivariable regression models were used to assess the relationship between post-transplant status and patient outcomes. RESULTS: Among 1,818,973 patients, 0.45% (n = 8,212) had a history of solid organ transplantation (liver: n = 1,773, 21.6%; heart/lung: n = 1,087, 13.2%; kidney/pancreas: n = 4,891, 59.6%; and multiple: n = 461, 5.6%). In the unmatched cohort, patients who had a history of organ transplant were more likely to be male (64.1% vs 57.7%) and have Medicare insurance (71.7% vs 59.3%) (both P < .001). On multivariable analysis, prior transplant recipient status was associated with higher odds of postoperative complications (odds ratio 1.30, 95% confidence interval 1.22-1.38), 30-day readmission (odds ratio 1.42, 95% confidence interval 1.31-1.54), and in-hospital mortality (odds ratio 1.20, 95% confidence interval 1.03-1.40) (all P < .05). Moreover, organ transplantation was associated with higher index hospitalization costs (14.4% difference, 95% confidence interval 14.1%-14.6%) and 30-day postdischarge costs (16.2% difference, 95% confidence interval 15.3%-17.0%) (both P < .001). CONCLUSIONS: Prior transplant recipient status was associated with adverse clinical and financial outcomes following subsequent major surgery. Prior history of transplant may be an important factor to incorporate into risk stratification of patients undergoing subsequent major surgical procedures.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Mehdi Khan MM, Woldesenbet S, Munir MM, et al. Association of transplant recipient status with clinical and financial outcomes among patients undergoing major surgery. Surgery. 2024. PMID: 39609216. doi:10.1016/j.surg.2024.06.086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。